1.Study on technical preparation of dexchlorpheniramine film coated tablets 6mg with sustained release
Pharmaceutical Journal 2000;291(7):15-18
Sustained release film coated tablets containing dexchlorpheniramine maleate were prepared in such a structure as two-third of drug were dispersed in Eudragit RS 100 to form insoluble matrix that gradually releases drug by diffusional mechanism, the rest was dispersed in the immediate release part. The core tablets were compressed by a wet granulation process and the film coated tablets by a routine film coating process with Eudragit E suspension. The formed coated tablets have suitable technical characteristics. The third formulation with Eudragit RS- drug ratio 2:1 has got the dissolution extent and the release rate in vitro similar to those of Polaramine 6mg repetabs. They also meet the requirements invitro release rate versus time for sustained release capsules containing Chlorpheniramine maleate by USP XXIII. Therefore, these film coated tablets with dexchlorpheniramine maleate may be candidates for a sustained release dosage form
dexchlorpheniramine
;
Tablets
2.Dosage of metronidazole in tablets by HPLC in reverted phase:
Pharmaceutical Journal 1999;282(10):22-24
Quantitation of Metronidazole by reversed phase liquid chromatography using Supelco LC-ABZ column and a mobile phase containing an acid aqueous phase (pH
3.Preliminary study on application of some dosage methods of berberine chloride in raw material and berberin tablets
Pharmaceutical Journal 2005;0(1):22-24
Study on some methods used to quantify berberine chloride showed that the UV measuring and volumetric titration methods did not express only amount of berberine chloride itself. It is necessary to apply high- performance liquid chromatography (HPLC) to achieve the optimal conditions for better splitting, higher accuracy…in order to apply more widely in testing products commonly in market with many components combined to berberine chloride. To find out optimal methods, which are suitable with condition of present some pharmaceutical units, it is necessary to experiment continuously methods such as UV measuring and volumetric titration,… using HPLC method to compare.
Berberine
;
Tablets
4.An Evaluation of Short-term Isoprodian Treatment in Leprosy.
Korean Journal of Dermatology 1977;15(3):267-277
Twenty-three bacteriologically positive leprosy patients were randomly selected from a leprosarium, randomly divided into four treatment groups, and given vaying dosages of Isoprodian, the tablet contained INAH 175mg, Prothionamide 175mg and DDS 50 mg, for five months. Group I: Initial 1/2 tablet dose per week with 1/2 tablet increment every weeks until 12 tablets were being consumed w.
Humans
;
Leprosy*
;
Prothionamide
;
Tablets
5.Clinical Effects of Serenoa Repens(Permixon) on Chronic Prostatitis.
Jung Chul YUN ; Sang Kyu CHUNG
Korean Journal of Urology 1990;31(6):869-873
Chronic prostatitis has various symptoms and many problems in management. Recently a lipidosterolic extract of Serenoa Repens, Permixon has been reported to reveal potential antiandrogenic and anti inflammatory activities on prostate. Then we used Permixon on chronic prostatitis and following results were obtained. Permixon is administered orally in dose of 160mg., b.i.d. for 60 days in 31 cases of chronic prostatitis in 1st group, Permixon 160mg, with Cipro-floxacin 500mg, b.i.d. in 35 cases in 2nd group and Placebo 2 tablets, b.i.d. in 30 cases in 3rd group. In 1st group 36 cases(77.4%) were improved, 29 cases(82.8%) in 2nd group and 7 cases (23.3 %) of 3rd group were improved. Permixon is an effective drug in chronic prostatitis and there was no changes in laboratory findings and negligible side effects were noticed
Prostate
;
Prostatitis*
;
Serenoa*
;
Tablets
6.Clinical Evaluation of Cernilton in Chronic Prostatitis.
Korean Journal of Urology 1974;15(3):191-194
A microbiological extract of pollen, Cernilton was administered orally in dose of four tablets daily for 14 to 36 days in 25 cases of chronic prostatitis and following results were obtained. 1) Of the cases, 13 cases' (72%) Were improved and 7 cases(28%) were. not improved.. 2) No deleterious side effect were observed.
Pollen
;
Prostatitis*
;
Tablets
7.Clinical Evaluation of Cernilton in Chronic Prostatitis.
Korean Journal of Urology 1974;15(3):191-194
A microbiological extract of pollen, Cernilton was administered orally in dose of four tablets daily for 14 to 36 days in 25 cases of chronic prostatitis and following results were obtained. 1) Of the cases, 13 cases' (72%) Were improved and 7 cases(28%) were. not improved.. 2) No deleterious side effect were observed.
Pollen
;
Prostatitis*
;
Tablets
8.Study on evaluation of bioavailability of nifedipine tablets
Pharmaceutical Journal 1999;282(10):19-21
The HPLC method described herein has sufficient sensitivity to determine the pharmacokinetic parameters of nifedipine in plasma. A single dose cross study was carried out in volunteers comparing the test sustained release nifedipine formulation to Adalat retard tablets. Pharmacokenetic variables were calculated from the nifedipine plasma concentration data and evaluated statistically. The results showed the test formulation to be bioequivalent to the reference tablets.
Nifedipine
;
Biological Availability
;
tablets
9.Study on the trial preparation of the lidocaine containing soluble tablet in the bowels for treatment of arrhythmia
Journal of Vietnamese Medicine 2001;263(9):155-161
Since 1975, lidocaine has been made up in Friendship hospital with the name rythmocardyl as a dissoluble tablet in the bowels. The magistral formula and processing procedures have been studied and tested to reach the VNP II - 1994 and BP-1993 standards. The lethal dosage (LD50), the anti - ventricular fibrillation and anti-arrhythmic effects, the blood concentration of lidocaine taken orally at different times as well as the dissolution of rythmocardyl in the human body have been tested experimentally. The research have proven that lidocaine, taken orally has few side effects and is safe and effective to treat the cardiac arrhythmia, notably the ventricular extrasystoles
Lidocaine
;
Arrhythmia
;
tablets
;
therapeutics
10.Pharmacokinetics of ofloxacin tablets on Vietnamese patient
Pharmaceutical Journal 1999;282(10):13-17
This paper reports an open label study of the pharmacokinetics of ofloxacin conducted on 12 Vietnamese healthy volunteers (4 females, 8 males). Oflaxacin was adminitered as an oral tablet presentation. The mean peak concentration was 2.270.53 mg.liter-1, occuring at 1.300.31h after dosing. The AUCo-24was 16.532.02mg.h.liter-1, the half-time was 5.040.44h and the volume of distribution was 1.120.18 liter.kg-1. Results collected from this study were similar to those of previous studies.
Pharmacokinetics
;
Ofloxacin
;
tablets\